Unveiling 5 Analyst Insights On IDEAYA Biosciences
In the preceding three months, 5 analysts have released ratings for IDEAYA Biosciences (NASDAQ:IDYA), presenting a wide array…
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation For Darovasertib In Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
Oral presentation at ASCO 2024 scheduled for Monday, June 3, 2024, at 9:51 AM CDTThe abstract summary will be available on Thursday, May 23, 2024 at ~5:00pm ETSOUTH SAN FRANCISCO, Calif., April 24, 2024 /PRNewswire/
Recap: IDEAYA Biosciences Q4 Earnings
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q4 earnings results on Tuesday, February 20, 2024 at 06:00 AM. Here’s what…
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
Analysts’ ratings for IDEAYA Biosciences (NASDAQ:IDYA) over the last quarter vary from bullish to bearish, as provided by…
Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here’s What You Need To Know
Goldman Sachs has decided to maintain its Buy rating of IDEAYA Biosciences (NASDAQ:IDYA) and raise its price target…
Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know
In the latest quarter, 7 analysts provided ratings for IDEAYA Biosciences (NASDAQ:IDYA), showcasing a mix of bullish and…
IDEAYA Biosciences Says Balance Sheet Of $511.1M Of Cash, Cash Equivalents And Marketable Securities As Of September 30, 2023, And $134.7M Est. Net Proceeds From Follow-On Financing And $10M Receivable From GSK, Is Anticipated To Fund Operations Into 2…
IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 42nd Annual J.P. Morgan Healthcare
8 Analysts Have This to Say About IDEAYA Biosciences
Within the last quarter, IDEAYA Biosciences (NASDAQ:IDYA) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
The Latest Analyst Ratings for IDEAYA Biosciences
IDEAYA Biosciences (NASDAQ:IDYA) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.